New research has revealed a possible breakthrough in the treatment of age-related macular degeneration (AMD). A team of scientists have developed a nanomedicine treatment using photoactivatable nanocarriers, which could be used to deliver drugs specifically to damaged areas of the eye. By using light to activate the nanocarriers, the drugs can be released directly into the targeted area, reducing the risk of side effects. This method of treatment could revolutionize the way AMD is treated, providing a safer and more targeted approach.

Read Full Article Here

source: Phys.org